|
⚲
|
| Keyboard |
| Apple Tree Partners IV LP
✚
|
|
|---|---|
| CIK # | 0001593440 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001593440] | |
| 3 | [0001593440] | |
| 4 | [0001593440] | |
| SC 13D | [0001593440] | |
| SC 13G | [0001593440] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akero Therapeutics Inc AKRO
Common Stock
|
2021-06-28 | Other | 5,830,203 | ||
|
Stoke Therapeutics Inc STOK
Common Stock
|
2021-06-28 | Other | 17,161,713 | ||
|
Stoke Therapeutics Inc STOK
Common Stock
|
2020-11-24 | Buy | 375,000 | $39.00 | 14,625,000 |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2020-07-10 | Buy | 415,000 | $36.00 | 14,940,000 |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2019-06-24 | Buy | 900,000 | $16.00 | 14,400,000 |
|
Akero Therapeutics Inc AKRO
Common Stock
|
2019-06-24 | Conversion | 286,439 | ||
|
Akero Therapeutics Inc AKRO
Common Stock
|
2019-06-24 | Conversion | 4,228,764 | ||
|
Akero Therapeutics Inc AKRO
Series B Preferred Stock · derivative
|
2019-06-24 | Conversion | 880,568 | $0.00 | |
|
Akero Therapeutics Inc AKRO
Series A Preferred Stock · derivative
|
2019-06-24 | Conversion | 13,000,000 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Series A-2 Convertible Preferred Stock · derivative
|
2019-06-21 | Conversion | 7,617,746 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Series A Convertible Preferred Stock · derivative
|
2019-06-21 | Conversion | 4,980,168 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Series B Convertible Preferred Stock · derivative
|
2019-06-21 | Conversion | 2,799,910 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Common Stock
|
2019-06-21 | Conversion | 4,980,168 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Common Stock
|
2019-06-21 | Conversion | 2,799,910 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Common Stock
|
2019-06-21 | Conversion | 7,617,746 | $0.00 | |
|
Stoke Therapeutics Inc STOK
Common Stock
|
2019-06-21 | Buy | 1,388,889 | $18.00 | 25,000,002 |
|
Avalo Therapeutics Inc CERC
Common Stock
|
2015-10-20 | Conversion | 595,436 | ||
|
Avalo Therapeutics Inc CERC
Series B Convertible Preferred Stock · derivative
|
2015-10-20 | Conversion | 16,672,224 | $0.00 |